Harbin Pharmaceutical Group Co., Ltd. (600664.SS)
Harbin Pharmaceutical Group Co., Ltd., engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally.
5.89+0.06%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+45.8%
The outlook
Harbin Pharmaceutical Group Co., Ltd. currently reads as bullish based on above its 50- & 200-day averages, 87% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range87% of the way from its 52-week low to high
Market cap
$14.83B
52-wk high
6.35
52-wk low
2.84
50-day avg
3.75
200-day avg
3.65
Trailing P/E
49.1